欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3934/002
药品名称Grenalvon 1 mg harde capsules
活性成分
    • anagrelide 1.0 mg
剂型Capsule, hard
上市许可持有人Alvogen Malta Operations (ROW) Ltd Malta Life Sciences Park, Building 1, Level 4, Sir Temi Zammit Buildings, San Gwann SGN 3000 Malta
参考成员国 - 产品名称Netherlands (NL)
Grenalvon 1 mg harde capsules
互认成员国 - 产品名称
    • Romania (RO)
许可日期2017/10/05
最近更新日期2023/06/21
药物ATC编码
    • L01XX35 anagrelide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase